A Study to Measure Whether PF-06480605 is Safe and Effective in the Treatment of Moderate to Severe Ulcerative Colitis

A Phase 2a, Multicenter, Single Arm, Open-Label, Two-Stage, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis

Category & Conditions: Immune System Diseases and Conditions

Medicine: PF-06480605

ClinicalTrials.gov Identifier (NCT): NCT02840721

Protocol ID: B7541002

Print Download

Open Plain Language Summary Result: Click here